Click here to download our September 10, 2007 press release.
Quinnova Pharmaceuticals, Inc. announced today the commercial launch of its second, water-lipid based foam prescription drug product utilizing the patented Proderm Technology™.
Click here to download our September 10, 2007 press release.
Quinnova Pharmaceuticals, Inc. announced the commercial launch of Hydro 40™ Foam. Containing 40 percent urea in a water-lipid based foam.
Click here to download our June 13, 2007 press release.
Quinnova has completed a $13.6 million private equity financing with participation from Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.
Click here to download our November 28, 2006 press release.